Glucagon amyloid-like fibril morphology is selected via morphology-dependent growth inhibition

Biochemistry

Volumn 46, Issue 24, 2007, Pages 7314-7324

  Andersen, Christian Beyschau ^a,b   Otzen, Daniel ^b   Christiansen, Gunna ^c   Rischel, Christian ^a  

^a NOVO NORDISK A S   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CONCENTRATION (PROCESS); CONFORMATIONS; ELECTRON MICROSCOPY; GROWTH KINETICS; PEPTIDES;

FIBRIL GROWTH; FIBRIL MORPHOLOGY; GLUCAGON; GROWTH INHIBITION;

HORMONES;

AMYLOID; GLUCAGON;

ARTICLE; CHEMICAL REACTION KINETICS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; LIGHT SCATTERING; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE;

AMYLOID; CIRCULAR DICHROISM; FLUORESCENT DYES; GLUCAGON; KINETICS; MICROSCOPY, ELECTRON; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; OSMOLAR CONCENTRATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, QUATERNARY; THIAZOLES;

EID: 34250872212     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi6025374     Document Type: Article

References (44)

1. Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G., and Dobson, C. M. (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils, Proc. Natl. Acad. Sci. U.S.A. 96, 3590-3594.
2. Frokjaer, S., and Otzen, D. E. (2005) Protein drug stability: A formulation challenge, Nat. Rev. Drug Discovery 4, 298-306.
3. Pedersen, J. S., Dikov, D., Flink, J. L., Hjuler, H. A., Christiansen, G., and Otzen, D. E. (2006) The changing face of glucagon fibrillation: Structural polymorphism and conformational imprinting, J. Mol. Biol. 355, 501-523.
4. Pedersen, J. S., Flink, J. M., Dikov, D., and Otzen, D. E. (2006) Sulfates dramatically stabilize a salt-dependent type of glucagon fibrils, Biophys. J. 90, 4181-4194.
5. Dong, M., Hovgaard, M. B., Xu, S., Otzen, D., and Besenbacher, F. (2006) AFM Study of glucagon fibrillation via oligomeric structures resulting in interwoven fibrils, Nanotechnology 17.
6. Pedersen, J. S., Dikov, D., and Otzen, D. E. (2006) N- and C-terminal hydrophobic patches are involved in fibrillation of glucagon, Biochemistry 45, 14503-14512.
7. Ferrone, F. (1991) Analysis of protein aggregation kinetics, in Methods Enzymol., 256-274.
8. Lindner, H., and Glatter, O. (2000) Determination of absolute intensity and molecular weight of small colloidal particles in the presence of some large aggregates. A combined study using static and dynamic light scattering, Part. Part. Syst. Charact. 17, 89-95.
9. Oberer, M., Lindner, H., Glatter, O., Kratky, C., and Keller, W. (1999) Thermodynamic properties and DNA binding of the ParD protein from the broad host-range plasmid RK2/RP4 killing system, Biol. Chem. 380, 1413-1420.
10. van Holde, K. E., Johnson, W. C., and Ho, P. S. (1998) Principles of Physical Biochemistry, Prentice Hall, Upper Saddle River, NJ.
11. Foxes Team (2006) MATRIX.xla version 2.1.
12. Stromer, T., and Serpell, L. C. (2005) Structure and morphology of the Alzheimer's amyloid fibril, Microsc. Res. Tech. 67, 210-217.
13. Gratzer, W. B., Creeth, J. M., and Beaven, G. H. (1972) Presence of trimers in glucagon solution, Eur. J. Biochem. 31, 505-509.
14. Beaven, G. H., Gratzer, W. B., and Davies, H. G. (1969) Formation and structure of gels and fibrils from glucagon, Eur. J. Biochem. 11, 37.
15. Glenner, G. G., Eanes, E. D., Bladen, H. A., Linke, R. P., and Termine, J. D. (1974) Beta-pleated sheet fibrils - Comparison of native amyloid with synthetic protein fibrils, J. Histochem. Cytochem. 22, 1141-1158.
16. Dobson, C. M. (2003) Protein folding and misfolding, Nature 426, 884-890.
17. Sluzky, V., Tamada, J. A., Klibanov, A. M., and Langer, R. (1991) Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces, Proc. Natl. Acad. Sci. U.S.A. 88, 9377-9381.
18. Naiki, H., Higuchi, K., Nakakuki, K., and Takeda, T. (1991) Kinetic analysis of amyloid fibril polymerization in vitro, Lab. Invest. 65, 104-110.
19. Jarrett, J. T., and Lansbury, P. T., Jr. (1992) Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB, Biochemistry 31, 12345-12352.
20. Come, J. H., Fraser, P. E., and Lansbury, P. T., Jr. (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding, Proc. Natl. Acad. Sci. U.S.A. 90, 5959-5963.
21. Dzwolak, W., Smirnovas, V., Jansen, R., and Winter, R. (2004) Insulin forms amyloid in a strain-dependent manner: an FT-IR spectroscopic study, Protein Sci. 13, 1927-1932.
22. Morozova-Roche, L. A., Zurdo, J., Spencer, A., Noppe, W., Receveur, V., Archer, D. B., Joniau, M., and Dobson, C. M. (2000) Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants, J. Struct. Biol. 130, 339-351.
23. Ramirez-Alvarado, M., and Regan, L. (2002) Does the location of a mutation determine the ability to form amyloid fibrils?, J. Mol. Biol. 323, 17-22.
24. Jones, E. M., and Surewicz, W. K. (2005) Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids, Cell 121, 63-72.
25. Vanik, D. L., Surewicz, K. A., and Surewicz, W. K. (2004) Molecular basis of barriers for interspecies transmissibility of mammalian prions, Mol. Cell 14, 139-145.
26. Lundmark, K., Westermark, G. T., Olsen, A., and Westermark, P. (2005) Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism, Proc. Natl. Acad. Sci. U.S.A. 102, 6098-6102.
27. Dzwolak, W., Ravindra, R., Lendermann, J., and Winter, R. (2003) Aggregation of bovine insulin probed by DSC/PPC calorimetry and FTIR spectroscopy, Biochemistry 42, 11347-11355.
28. Yagi, H., Kusaka, E., Hongo, K., Mizobata, T., and Kawata, Y. (2005) Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases, J. Biol. Chem. 280, 38609-38616.
29. O'Nuallain, B., Williams, A. D., Westermark, P., and Wetzel, R. (2004) Seeding specificity in amyloid growth induced by heterologous fibrils, J. Biol. Chem. 279, 17490-17499.
30. Hong, D. P., and Fink, A. L. (2005) Independent heterologous fibrillation of insulin and its B-chain peptide, Biochemistry 44, 16701-16709.
31. Petkova, A. T., Leapman, R. D., Guo, Z. H., Yau, W. M., Mattson, M. P., and Tycko, R. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils, Science 307, 262-265.
32. Hasegawa, K., Yamaguchi, I., Omata, S., Gejyo, F., and Naiki, H. (1999) Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro, Biochemistry 38, 15514-15521.
33. Gratzer, W. B., Beaven, G. H., Rattle, H. W. E., and Bradbury, E. M. (1968) A conformational study of glucagon, Eur. J. Biochem. 3, 276.
34. Blundell, T. L. (1983) The conformation of glucagon, in Handbook of Experimental Pharmacology (Lefebvre, P., Ed.) 66/I ed., pp 37-56, Springer-Verlag, Berlin.
35. Sasaki, K., Dockerill, S., Adamiak, D. A., Tickle, I. J., and Blundell, T. (1975) X-ray analysis of glucagon and its relationship to receptor-binding, Nature 257, 751-757.
36. Wagman, M. E., Dobson, C. M., and Karplus, M. (1980) Proton NMR-studies of the association and folding of glucagon in solution, FEBS Lett. 119, 265-270.
37. Srere, P. A., and Brooks, G. C. (1969) The circular dichroism of glucagon solutions, Arch. Biochem. Biophys. 129, 708-710.
38. Wu, C. S. C., and Yang, J. T. (1980) Helical conformation of glucagon in surfactant solutions, Biochemistry 19, 2117-2122.
39. Gratzer, W. B., and Beaven, G. H. (1969) Relation between conformation and association state - A study of association equilibrium of glucagon, J. Biol. Chem. 244, 6675.
40. Formisano, S., Johnson, M. L., and Edelhoch, H. (1977) Thermodynamics of self-association of glucagon, Proc. Natl. Acad. Sci. U.S.A. 74, 3340-3344.
41. Hong, D. P., Ahmad, A., and Fink, A. L. (2006) Fibrillation of human insulin A and B chains, Biochemistry 45, 9342-9353.
42. Khurana, R., Coleman, C., Ionescu-Zanetti, C., Carter, S. A., Krishna, V., Grover, R. K., Roy, R., and Singh, S. (2005) Mechanism of thioflavin T binding to amyloid fibrils, J. Struct. Biol. 151, 229-238.
43. Krebs, M. R. H., Bromley, E. H. C., and Donald, A. M. (2005) The binding of thioflavin-T to amyloid fibrils: localisation and implications, J. Struct. Biol. 149, 30-37.
44. Librizzi, F., and Rischel, C. (2005) The kinetic behavior of insulin fibrillation is determined by heterogeneous nucleation pathways, Protein Sci. 14, 3129-3134.